Aberrantly Expressed Timeless Regulates Cell Proliferation and Cisplatin Efficacy in Cervical Cancer.
Aberrantly Expressed Timeless Regulates Cell Proliferation and Cisplatin Efficacy in Cervical Cancer.
复制标题
DOI:
10.1089/hum.2019.080
复制
发表时间:
2019-12
影响因子:
4.2
通讯作者:
Jinhua Zhou;Yinghui Zhang;Xinwei Zou;Lingling Kuai;Li Wang;Juan Wang;F. Shen;Jinghui Hu;Xia Zhang;Ya-Ting Huang;Youguo Chen
中科院分区:
文献类型:
--
作者:
Jinhua Zhou;Yinghui Zhang;Xinwei Zou;Lingling Kuai;Li Wang;Juan Wang;F. Shen;Jinghui Hu;Xia Zhang;Ya-Ting Huang;Youguo Chen
Timeless is a regulator of molecular clockwork in Drosophila and related to cancer development in mammals. To investigate the effect of Timeless on cell proliferation and cisplatin sensitivity in cervical cancer. Timeless expression was determined by bioinformatical analysis, immunohistochemistry and QPCR. ChIP assays and reporter gene assays were applied to determine transcriptional factor contributing to Timeless upregulation. The effect of Timeless depletion on cell proliferation and cisplatin sensitivity were determined by in vitro and in vivo experiments. Cell apoptosis and senescence were assessed by flow cytometry and β-galactosidase staining. DNA damage and DNA repair pathway were determined by comet assay, immunofluorescent staining and western blot. Timeless is aberrantly expressed in approximately 52.5% of cervical cancer tissues. E2F1 and E2F4 contributes to transcriptional activation of Timeless. Timeless depletion inhibits cell proliferation and increases cisplatin sensitivity in vitro and in vivo. Timeless knockdown induces cell apoptosis and cell senescence. Mechanically, Timeless silencing leads to DNA damage and impairs the activation of ATR/CHK1 pathway in response to cisplatin in cervical cancer. Timeless is overexpressed in cervical cancer and regulates cell proliferation as well as cisplatin sensitivity, presenting an attractive target for cisplatin sensitizer in cervical cancer.